Glenn Sblendorio | Chairman of the Board
As Chairman of the Board, Mr. Sblendorio plays a pivotal role in ensuring the board’s effectiveness in implementing the Nanoscope mission to bring hope for renewed sight to millions of people affected by retinal degenerative diseases. He brings more than 30 years of exemplary experience to this role, marked by extensive executive leadership, financial acumen, and a proven track record of bringing innovative treatments to market. Mr. Sblendorio will help guide Nanoscope toward reaching its strategic vision.
Most recently, Mr. Sblendorio held various key leadership roles at IVERIC bio, Inc., an Astellas Company (formerly Ophthotech Corporation), including CEO, President, and Director. He also served as EVP, COO, CFO and Treasurer. Additionally, he served as President, CFO and Director at The Medicines Company and as EVP and CFO at Eyetech Pharmaceuticals. Earlier in his career, Mr. Sblendorio was a Managing Director at MPM Capital Advisors, LLC, and held various senior financial positions at Hoffman-La Roche.
Mr. Sblendorio holds a Bachelor of Business Administration degree from Pace University, a Master of Business Administration degree from Fairleigh Dickinson University and is a graduate of the Harvard Advanced Management Program.
